VistaGen Therapeutics
VTGN
$4.60
Share price
-0.43%
Change (1 day)
3,438.46%
Change (1 year)
Categories
VistaGen Therapeutics (VTGN) - Net assets
Net assets on the balance sheet as of December 2023 : $0.12 B
According to VistaGen Therapeutics
's latest financial reports the company has $0.12 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
VistaGen Therapeutics - Net assets on balance sheet (from 2008 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-03-31 | $12.08 M | -81.33% |
| 2022-03-31 | $64.71 M | -29.64% |
| 2021-03-31 | $91.97 M | -1705.38% |
| 2020-03-31 | $-5.73 M | -180.98% |
| 2019-03-31 | $7.07 M | 2.29% |
| 2018-03-31 | $6.91 M | 1023.19% |
| 2017-03-31 | $0.61 M | -120.68% |
| 2016-03-31 | $-2.98 M | -85.51% |
| 2015-03-31 | $-20.55 M | 60.49% |
| 2014-03-31 | $-12.8 M | 1.94% |
| 2013-03-31 | $-12.56 M | 120.07% |
| 2012-03-31 | $-5.71 M | |
| 2010-12-31 | $-0.01 M | 706.45% |
| 2009-12-31 | $-0.01 M | -100.61% |
| 2008-12-31 | $0.02 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.22 B | 81.76% | 🇺🇸 USA |